PD-1/PD-L1-IN-28
Product Specifications
UNSPSC Description
PD-1/PD-L1-IN-28 (compound 3) is an immune checkpoint inhibitor of PD-1/PD-L1 signaling pathway (IC50=0.744 µM). PD-1/PD-L1-IN-28 shows good research potential in tumor immunity[1].
Target Antigen
PD-1/PD-L1
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pd-1-pd-l1-in-28.html
Solubility
10 mM in DMSO
Smiles
OCCNCC1=CC=C(NC2=NN=C(C3=C(C)C(C4=CC=CC=C4)=CC=C3)O2)C=C1
Molecular Weight
400.47
References & Citations
[1]Jiang Sheng, et al. Preparation of phenyl substituted five membered heterocyclic compounds as immunocheckpoint inhibitors of PD-1 / PD-L1 signaling pathway. Patent WO2021031788A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-148305/PD-1-PD-L1-IN-28-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-148305/
Clinical Information
No Development Reported
CAS Number
2499965-07-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
LC427700 20 µg
Poliovirus Receptor (PVR) (NM_001135768) Human Over-expression Lysate
Ask
View Details 
